NCT03958955 - Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 9, 2019

Primary Completion Date

April 15, 2020

Study Completion Date

April 30, 2020

Conditions

Discoid Lupus Erythematosus

Interventions

DRUG

Delgocitinib cream

Cream for topical application.

DRUG

Delgocitinib cream vehicle

The cream vehicle is similar to the delgocitinib cream except that it does not contain any active ingredient.

Trial Locations (19)

2900

LEO Pharma Investigational site, Hellerup

5000

LEO Pharma Investigational Site, Odense

8200

LEO Pharma Investigational Site, Aarhus

10117

LEO Pharma Investigational Site, Berlin

11375

LEO Pharma Investigational Site, Forest Hills

26133

LEO Pharma Investigational Site, Oldenburg

31000

LEO Pharma Investigational Site, Toulouse

40225

LEO Pharma Investigational Site, Düsseldorf

42000

LEO Pharma Investigational Site, Loiré

44791

LEO Pharma Investigational Site, Bochum

45219

LEO Pharma Investigational Site, Cincinnati

52074

LEO Pharma Investigational Site, Aachen

60077

LEO Pharma Investigational Site, Skokie

75010

LEO Pharma Investigational Site, Paris

91054

LEO Pharma Investigational Site, Erlangen

92103

LEO Pharma Investigational Site, San Diego

02115

LEO Pharma Investigational Site, Boston

06202

LEO Pharma Investigational Site, Nice

01307

LEO Pharma Investigational Site, Dresden